NCT06914765
ESG in Obese Adolescents
Enrolling by Invitation
NAAges 12–17InterventionalTreatmentChildren's Hospital of PhiladelphiaInvestigator-initiated
~10 participants
Updated 2025-12-10 on ClinicalTrials.gov
What's tested:Endoscopic Sleeve Gastroplasty (ESG) Procedure
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Determine whether use of the Apollo Endosurgery ESG System is a safe, well tolerated intervention for weight loss in our study population
Measured over 24 months
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Study leadership
- Michael Manfredi, MD · PRINCIPAL_INVESTIGATOR · Children's Hospital of Philadelphia
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Determine whether use of the Apollo Endosurgery ESG System is a safe, well tolerated intervention for weight loss in our study population24 months
Number of procedure related adverse events will be collected. Severity of adverse events will be defined using the Clavien-Dindo Classification of Surgical Complications.